Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boehringer Ingelheim confirms BioWhittaker agreement:

This article was originally published in Clinica

Executive Summary

Boehringer Ingelheim has confirmed it will buy BioWhittaker's interest in the companies' joint venture for cell culture products in Verviers, Belgium (see Clinica No 653, p 13). Under the recently signed agreement, Boehringer Ingelheim says it intends to integrate the joint venture into its affiliated distributors in Spain, Austria and Germany. However, until the restructuring takes place, BioWhittaker will maintain its exclusive distribution arrangements in those countries. BioWhittaker has also agreed to sell to the joint venture its distribution subsidiary in France. Its UK subsidiary will continue to be the joint venture's exclusive distributor in the UK and Ireland. BioWhittaker has the option to repurchase its interest in the venture for an agreed price over a designated period.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091845

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel